2m 2m 2m 2m 2m 2m 2m
CANOPY GROW (CGC)
NASDAQ
$0.94-$0.002 (-0.23%)
Price as of Jun 23, 2026 7:54 PM EDT- $404.0MMarket Cap
- -24.30%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CANOPY GROW (CGC)
$0.94-$0.002 (-0.23%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 284.6M +5.80% | 269.0M -9.47% | 297.1M -26.25% | 402.9M -22.57% | |
Cost of Revenue | 214.9M +13.43% | 189.5M -12.38% | 216.3M -57.35% | 507.0M -28.92% | |
Gross Profit | 69.7M -12.38% | 79.5M -1.70% | 80.9M +177.67% | -104.1M -46.06% | |
Sales and Marketing Expense | 160.0M -5.68% | 169.6M -26.07% | 229.4M -49.71% | 456.2M -3.50% | |
Research and Development Expense | -2.6M -4.67% | -2.7M -40.53% | -4.6M -78.77% | -21.7M -32.85% | |
Depreciation and Amortization Expense | 17.4M -19.21% | 21.6M -12.92% | 24.8M -10.73% | 27.8M -27.22% | |
Total Operating Expenses | 231.3M +17.63% | 196.7M -36.48% | 309.6M -88.72% | 2.7B +208.46% | |
Operating Profit | -161.7M +38.00% | -117.1M -48.78% | -228.7M -91.97% | -2.8B +163.08% | |
Interest Income | 10.0M +13.41% | 8.8M -45.70% | 16.2M -33.14% | 24.3M +267.85% | |
Interest Expense | -38.2M -48.78% | -74.6M -29.22% | -105.4M -16.49% | -126.2M +21.37% | |
Interest Income and Expense and Net | -28.2M -57.12% | -65.8M -26.22% | -89.1M -12.53% | -101.9M +4.66% | |
Total Nonoperating Income and Expense | -101.2M -78.90% | -479.9M +97.76% | -242.6M -47.93% | -466.0M -161.86% | |
Income before Taxes | -262.9M -55.97% | -597.0M +26.66% | -471.4M -85.78% | -3.3B +906.07% | |
Income Taxes | 23,000 -99.68% | 7.1M -42.07% | 12.3M +358.21% | -4.8M -46.65% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 403.6M +51.65% | |
Net Income | -262.9M -56.04% | -598.1M -9.00% | -657.3M -79.95% | -3.3B +984.83% | |
Net Income from Continuing Operations Applicable to Common | -262.9M -55.97% | -597.0M +26.66% | -471.4M -85.78% | -3.3B +906.07% | |
Basic EPS and Net Income | -0.88 -84.17% | -5.56 -36.75% | -8.79 +24.33% | -7.07 +818.18% | |
Diluted EPS and Net Income | -0.88 -84.17% | -5.56 -36.75% | -8.79 +24.33% | -7.07 +818.18% | |
Basic Weighted Average Shares | 298.0M +177.11% | 107.6M +43.81% | 74.8M -83.87% | 463.7M +18.50% | |
Diluted Weighted Average Shares | 298.0M +177.11% | 107.6M +43.81% | 74.8M -83.87% | 463.7M +18.50% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 364.7M +220.43% | 113.8M -33.17% | 170.3M -74.85% | 677.0M -12.76% | |
Short-Term Investments | 0 -100.00% | 17.7M -46.76% | 33.2M -68.60% | 105.6M -82.27% | |
Cash and Cash Equivalents and Short-Term Investments | 364.7M +177.40% | 131.5M -35.38% | 203.5M -74.00% | 782.6M -42.94% | |
Total Current Assets | 529.5M +79.74% | 294.6M -20.64% | 371.2M -65.54% | 1.1B -38.00% | |
Accumulated Depreciation | 131.4M +17.34% | 112.0M +14.04% | 98.2M -12.34% | 112.0M -51.91% | |
Property and Plant and Equipment and Net | 316.5M +7.83% | 293.5M -8.30% | 320.1M -35.91% | 499.5M -47.02% | |
Total Long-Term Assets | 16.7M +1.71% | 16.4M -32.09% | 24.1M +21.82% | 19.8M +29.08% | |
Total Assets | 1.1B +21.91% | 917.7M -29.43% | 1.3B -46.69% | 2.4B -56.56% | |
Income Taxes Payable | 8.2M +1,965.24% | 397,000 -22.46% | 512,000 +43.42% | 357,000 -97.77% | |
Total Short-Term Debt | 16.2M +281.33% | 4.3M -95.90% | 103.9M -81.34% | 556.9M +5,890.64% | |
Total Current Liabilities | 158.4M +67.84% | 94.4M -59.78% | 234.7M -70.80% | 803.8M +277.57% | |
Total Long-Term Debt | 217.1M -27.58% | 299.8M -39.22% | 493.3M -34.23% | 750.0M -49.72% | |
Total Long-Term Liabilities | 37.4M +3.03% | 36.3M -49.49% | 71.8M -42.50% | 124.9M -34.29% | |
Total Liabilities | 421.1M -2.17% | 430.5M -46.18% | 799.8M -52.37% | 1.7B -15.39% | |
Retained Earnings | -11.1B +1.92% | -10.9B +5.79% | -10.3B +6.80% | -9.7B +51.84% | |
Total Stockholders Equity | 697.6M +43.18% | 487.2M -2.63% | 500.4M -34.03% | 758.4M -78.87% | |
Total Shares Outstanding | 422.1M +129.55% | 183.9M +101.79% | 91.1M -82.39% | 517.3M +31.16% | |
Cash Flow | |||||
Cash from Operating Activities | -63.8M -61.50% | -165.8M -41.21% | -281.9M -49.43% | -557.5M +2.15% | |
Capital Expenditures | 5.3M -50.68% | 10.8M +213.51% | 3.4M -62.58% | 9.2M -74.87% | |
Cash from Investing Activities | -21.3M -55.33% | -47.8M -119.78% | 241.6M -44.25% | 433.4M +87.76% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 332.4M +123.60% | 148.7M +131.97% | -465.1M +2,261.40% | -19.7M -56.75% | |
Financials Ratio | |||||
Gross Margin | 24.48% -17.18% | 29.56% +8.59% | 27.22% +205.31% | -25.85% -30.34% | |
Operating Margin | -56.80% +30.43% | -43.55% -43.42% | -76.97% -89.11% | -706.94% +239.75% | |
Return on Assets | -25.82% -52.12% | -53.93% +53.42% | -35.15% -56.82% | -81.40% +1,575.37% | |
Return on Equity | -44.38% -63.36% | -121.13% +15.99% | -104.43% -30.74% | -150.78% +1,664.26% | |
Revenue Growth | 5.80% +161.25% | -9.47% -63.91% | -26.25% +16.32% | -22.57% +368.63% | |
Current Ratio | 3.34 +7.09% | 3.12 +97.32% | 1.58 +18.01% | 1.34 -83.58% | |
Cash Ratio | 2.30 +90.92% | 1.21 +66.15% | 0.73 -13.84% | 0.84 -76.89% | |
Debt-to-Equity Ratio | 0.33 -46.40% | 0.62 -47.71% | 1.19 -30.73% | 1.72 +312.13% | |
Debt-to-Assets Ratio | 0.21 -37.04% | 0.33 -27.87% | 0.46 -14.28% | 0.54 +100.45% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow